EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Changes in bone density and microarchitecture following treatment of Graves’ disease and the effects of vitamin D supplementation. A randomized clinical trial

Diana Grove-Laugesen, Eva Ebbehoj, Torquil Watt, Klavs Würgler Hansen, Lars Rejnmark

Osteoporosis International · 2024

DOI: 10.1007/s00198-024-07241-y ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Osteoporosis International, 2024. Verfasst von Diana Grove-Laugesen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. dianagrove@clin.au.dk. Hauptthemen laut MEDLINE: Graves Disease, Bone Density, Antithyroid Agents, Dietary Supplements. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Aarhus University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyrotoxicosis leads to loss of bone mass. Vitamin D is important to bone health. In this randomized, placebo-controlled trial, we showed that bone restoration did not improve when adding vitamin D supplementation to standard care of Graves' disease thyrotoxicosis. Bone density and microarchitecture improved markedly with treatment of thyrotoxicosis. PURPOSE: Vitamin D is important to skeletal health and ensuring a replete vitamin D status is recommended. In thyrotoxicosis, bone turnover is increased and bone mass density (BMD) reduced. We examined whether vitamin D supplementation improves bone recovery in thyrotoxicosis caused by Graves' disease (GD). METHODS: Using a double-blinded design, hyperthyroid patients with GD were randomized to vitamin D3 70 µg/day (2800 IU) or similar placebo as add-on to antithyroid drugs (ATD). At baseline and 9 months, we measured BMD and bone architecture using DXA and high resolution peripheral quantitative computerized tomography. Bone turnover markers (BTM) were measured at 3 months also. Effect of vitamin D versus placebo and the response to ATD treatment were analyzed using linear mixed modelling. RESULTS: Eighty-six GD patients were included (age 41 ± 14 years, 86% females). Compared to placebo, vitamin D3 did not improve BMD or microarchitecture. In response to ATD, BMD increased in the hip by 2% (95%CI: 1-4%). Cortical porosity decreased in tibia (- 7% [95%CI: - 12 to - 2%]) and radius [- 14% [95%CI: - 24 to - 3%]), and trabecular thickness increased (tibia (5% [95%CI: 2 - 9%]) and radius (4% [95%CI: 1-7%]). Changes in BTM, but not thyroid hormones, were associated with changes in BMD by DXA and with changes in the cortical compartment. CONCLUSION: In newly diagnosed GD, 9 months of high dose vitamin D3 supplementation does not offer benefit by improving skeletal health. Treatment of thyrotoxicosis is associated with the recovery of BMD and microarchitecture. GOV IDENTIFIER: NCT02384668.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseBone DensityAntithyroid AgentsDietary SupplementsCholecalciferolBone RemodelingAbsorptiometry, PhotonHumansFemaleDouble-Blind MethodMaleAdultMiddle AgedDrug Therapy, CombinationThyrotoxicosisBone Density Conservation AgentsTomography, X-Ray ComputedLumbar VertebraeVitamin DYoung Adult

Stichwörter der Autor:innen

Bone densityBone microarchitectureBone turnover markersGraves’ diseaseThyrotoxicosisVitamin D

Substanzen

Antithyroid AgentsCholecalciferolBone Density Conservation AgentsVitamin D

Autor:innen und Institutionen

  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. dianagrove@clin.au.dk.
  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Endocrinology and Metabolism, Rigshospitalet, Copenhagen, Denmark.
  • Diagnostic Centre, Silkeborg Regional Hospital, Silkeborg, Denmark.

Förderung

  • Aarhus University Hospital

Zitieren

APA

Grove-Laugesen, D., Ebbehoj, E., Watt, T., Hansen, K. W., & Rejnmark, L. (2024). Changes in bone density and microarchitecture following treatment of Graves’ disease and the effects of vitamin D supplementation. A randomized clinical trial. Osteoporosis International. https://doi.org/10.1007/s00198-024-07241-y

Vancouver

Grove-Laugesen D, Ebbehoj E, Watt T, Hansen KW, Rejnmark L. Changes in bone density and microarchitecture following treatment of Graves’ disease and the effects of vitamin D supplementation. A randomized clinical trial. Osteoporosis International. 2024. doi:10.1007/s00198-024-07241-y

BibTeX
@article{GroveLaugesen2024,
  author = {Grove-Laugesen, Diana and Ebbehoj, Eva and Watt, Torquil and Hansen, Klavs Würgler and Rejnmark, Lars},
  title = {Changes in bone density and microarchitecture following treatment of Graves’ disease and the effects of vitamin D supplementation. A randomized clinical trial},
  journal = {Osteoporosis International},
  year = {2024},
  doi = {10.1007/s00198-024-07241-y}
}
Kostenlos starten →